C
Charles Lassman
Researcher at University of California, Los Angeles
Publications - 88
Citations - 7898
Charles Lassman is an academic researcher from University of California, Los Angeles. The author has contributed to research in topics: Liver transplantation & Transplantation. The author has an hindex of 43, co-authored 88 publications receiving 7323 citations. Previous affiliations of Charles Lassman include UCLA Medical Center.
Papers
More filters
Journal ArticleDOI
Upregulation of heme oxygenase-1 protects genetically fat Zucker rat livers from ischemia/reperfusion injury.
Farin Amersi,Roland Buelow,Hirohisa Kato,Bibo Ke,Ana J. Coito,Xiu Da Shen,D. Zhao,Joseph Zaky,Judy Melinek,Charles Lassman,Jay K. Kolls,Jawed Alam,Thomas Ritter,Hans-Dieter Volk,Douglas G. Farmer,Rafik M. Ghobrial,Ronald W. Busuttil,Jerzy W. Kupiec-Weglinski,Jerzy W. Kupiec-Weglinski +18 more
TL;DR: The findings provide the rationale for refined new treatments that should increase the supply of usable donor livers and ultimately improve the overall success of liver transplantation.
Journal ArticleDOI
Effect of vessel size on creation of hepatic radiofrequency lesions in pigs: assessment of the "heat sink" effect.
TL;DR: There appears to be a narrow transition zone for hepatic vessels at 2-4 mm, beyond which the heat sink effect was seen consistently and substantial vascular injury was rare.
Journal ArticleDOI
Cutting Edge: TLR4 Activation Mediates Liver Ischemia/Reperfusion Inflammatory Response via IFN Regulatory Factor 3-Dependent MyD88-Independent Pathway
Yuan Zhai,Xiu Da Shen,Ryan M. O'Connell,Feng Gao,Charles Lassman,Ronald W. Busuttil,Genhong Cheng,Jerzy W. Kupiec-Weglinski +7 more
TL;DR: The results show that IFN regulatory factor 3, but not MyD88, mediated IRI-induced TLR4 activation leading to liver inflammation and hepatocellular damage.
Journal ArticleDOI
Update of the International Banff Schema for Liver Allograft Rejection: working recommendations for the histopathologic staging and reporting of chronic rejection. An International Panel.
Anthony J. Demetris,David H. Adams,Christopher Bellamy,Karin Blakolmer,Andrew D. Clouston,Amar P. Dhillon,John J. Fung,Annette S. H. Gouw,Bengt Gustafsson,Hironori Haga,David J. Harrison,John Hart,Stefan G. Hubscher,R. Jaffe,Urmila Khettry,Charles Lassman,Klaus J. Lewin,Olivia M. Martinez,Yuichi Nakazawa,Desley Neil,Orit Pappo,Maria Parizhskaya,Parmjeet Randhawa,Susanne Rasoul-Rockenschaub,Finn Reinholt,Michel Reynes,Marie E. Robert,Athanassios C. Tsamandas,Ian R. Wanless,Russell H. Wiesner,Annika Wernerson,Fritz Wrba,Judy Wyatt,Hirohiko Yamabe +33 more
Journal ArticleDOI
Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA.
John P. Duffy,Andrew J. Vardanian,Elizabeth Benjamin,Melissa J. Watson,Douglas G. Farmer,Rafik M. Ghobrial,Gerald S. Lipshutz,Hasan Yersiz,David S.K. Lu,Charles Lassman,Myron J. Tong,Jonathan R. Hiatt,Ronald W. Busuttil +12 more
TL;DR: This largest single institution experience with OLT for HCC demonstrates prolonged survival after liver transplantation for tumors beyond Milan criteria but within UCSF criteria, both when classified by preoperative imaging and by explant pathology.